These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 7882365

  • 1. Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer.
    Dosaka-Akita H, Akie K, Hiroumi H, Kinoshita I, Kawakami Y, Murakami A.
    Cancer Res; 1995 Apr 01; 55(7):1559-64. PubMed ID: 7882365
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of all-trans-retinoic acid-mediated L-myc gene regulation in small cell lung cancer.
    Ou X, Campau S, Slusher R, Jasti RK, Mabry M, Kalemkerian GP.
    Oncogene; 1996 Nov 07; 13(9):1893-9. PubMed ID: 8934535
    [Abstract] [Full Text] [Related]

  • 3. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
    Ma PC, Kijima T, Maulik G, Fox EA, Sattler M, Griffin JD, Johnson BE, Salgia R.
    Cancer Res; 2003 Oct 01; 63(19):6272-81. PubMed ID: 14559814
    [Abstract] [Full Text] [Related]

  • 4. Association of the decreased expression of alpha3beta1 integrin with the altered cell: environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells.
    Barr LF, Campbell SE, Bochner BS, Dang CV.
    Cancer Res; 1998 Dec 01; 58(23):5537-45. PubMed ID: 9850091
    [Abstract] [Full Text] [Related]

  • 5. Co-amplification of a novel cyclophilin-like gene (PPIE) with L-myc in small cell lung cancer cell lines.
    Kim JO, Nau MM, Allikian KA, Mäkelä TP, Alitalo K, Johnson BE, Kelley MJ.
    Oncogene; 1998 Aug 27; 17(8):1019-26. PubMed ID: 9747881
    [Abstract] [Full Text] [Related]

  • 6. c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression.
    Barr LF, Campbell SE, Diette GB, Gabrielson EW, Kim S, Shim H, Dang CV.
    Cancer Res; 2000 Jan 01; 60(1):143-9. PubMed ID: 10646866
    [Abstract] [Full Text] [Related]

  • 7. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
    Robinson LA, Smith LJ, Fontaine MP, Kay HD, Mountjoy CP, Pirruccello SJ.
    Ann Thorac Surg; 1995 Dec 01; 60(6):1583-91. PubMed ID: 8787447
    [Abstract] [Full Text] [Related]

  • 8. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
    Bepler G, Bading H, Heimann B, Kiefer P, Havemann K, Moelling K.
    Oncogene; 1989 Jan 01; 4(1):45-50. PubMed ID: 2536917
    [Abstract] [Full Text] [Related]

  • 9. A combination treatment of c-myc antisense DNA with all-trans-retinoic acid inhibits cell proliferation by downregulating c-myc expression in small cell lung cancer.
    Akie K, Dosaka-Akita H, Murakami A, Kawakami Y.
    Antisense Nucleic Acid Drug Dev; 2000 Aug 01; 10(4):243-9. PubMed ID: 10984118
    [Abstract] [Full Text] [Related]

  • 10. All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer.
    Kalemkerian GP, Jasti RK, Celano P, Nelkin BD, Mabry M.
    Cell Growth Differ; 1994 Jan 01; 5(1):55-60. PubMed ID: 8123593
    [Abstract] [Full Text] [Related]

  • 11. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
    Kim YH, Girard L, Giacomini CP, Wang P, Hernandez-Boussard T, Tibshirani R, Minna JD, Pollack JR.
    Oncogene; 2006 Jan 05; 25(1):130-8. PubMed ID: 16116477
    [Abstract] [Full Text] [Related]

  • 12. Eradication of Myc-overexpressing small cell lung cancer cells transfected with herpes simplex virus thymidine kinase gene containing Myc-Max response elements.
    Kumagai T, Tanio Y, Osaki T, Hosoe S, Tachibana I, Ueno K, Kijima T, Horai T, Kishimoto T.
    Cancer Res; 1996 Jan 15; 56(2):354-8. PubMed ID: 8542591
    [Abstract] [Full Text] [Related]

  • 13. Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines.
    van Waardenburg RC, Meijer C, Pinto-Sietsma SJ, de Vries EG, Timens W, Mulder NM.
    Anticancer Res; 1998 Jan 15; 18(1A):91-5. PubMed ID: 9568061
    [Abstract] [Full Text] [Related]

  • 14. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.
    Risse-Hackl G, Adamkiewicz J, Wimmel A, Schuermann M.
    Oncogene; 1998 Jun 11; 16(23):3057-68. PubMed ID: 9662339
    [Abstract] [Full Text] [Related]

  • 15. The growth inhibitory effect of N1,N12-bis(ethyl)spermine in small cell lung cancer cells is maintained in cells expressing the c-myc and Ha-ras oncogenes.
    Barr LF, Campbell SE, Tamez P, Casero RA.
    Clin Cancer Res; 1998 Jun 11; 4(6):1557-61. PubMed ID: 9626477
    [Abstract] [Full Text] [Related]

  • 16. Protein kinase C-beta 2 inhibits cycling and decreases c-myc-induced apoptosis in small cell lung cancer cells.
    Barr LF, Campbell SE, Baylin SB.
    Cell Growth Differ; 1997 Apr 11; 8(4):381-92. PubMed ID: 9101084
    [Abstract] [Full Text] [Related]

  • 17. A group of deltanoids (vitamin D analogs) regulate cell growth and proliferation in small cell carcinoma cell lines.
    Güzey M, DeLuca HF.
    Res Commun Mol Pathol Pharmacol; 1997 Oct 11; 98(1):3-18. PubMed ID: 9434311
    [Abstract] [Full Text] [Related]

  • 18. The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells.
    Gilbert JA, Frederick LM, Ames MM.
    Clin Cancer Res; 2000 Nov 11; 6(11):4365-72. PubMed ID: 11106255
    [Abstract] [Full Text] [Related]

  • 19. Additive and differential biological activity of alpha-interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines.
    Bepler G, Carney DN, Nau MM, Gazdar AF, Minna JD.
    Cancer Res; 1986 Jul 11; 46(7):3413-9. PubMed ID: 3085922
    [Abstract] [Full Text] [Related]

  • 20. Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3.
    Tanno S, Ohsaki Y, Nakanishi K, Toyoshima E, Kikuchi K.
    Lung Cancer; 2004 Oct 11; 46(1):11-9. PubMed ID: 15364128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.